Entera Bio Ltd. (ENTX)
Entera Bio Ltd. Statistics
Share Statistics
Entera Bio Ltd. has 41.74M shares outstanding. The number of shares has increased by 16.52% in one year.
| Shares Outstanding | 41.74M |
| Shares Change (YoY) | 16.52% |
| Shares Change (QoQ) | 13.31% |
| Owned by Institutions (%) | 19.95% |
| Shares Floating | 36.62M |
| Failed to Deliver (FTD) Shares | 382 |
| FTD / Avg. Volume | 0.32% |
Short Selling Information
The latest short interest is 95.79K, so 0.26% of the outstanding shares have been sold short.
| Short Interest | 95.79K |
| Short % of Shares Out | 0.26% |
| Short % of Float | 0.32% |
| Short Ratio (days to cover) | 0.45 |
Valuation Ratios
The PE ratio is 8.39 and the forward PE ratio is -4.24. Entera Bio Ltd.'s PEG ratio is -0.05.
| PE Ratio | 8.39 |
| Forward PE | -4.24 |
| PS Ratio | 440.99 |
| Forward PS | 1.3 |
| PB Ratio | 9.88 |
| P/FCF Ratio | -11.7 |
| PEG Ratio | -0.05 |
Enterprise Valuation
Entera Bio Ltd. has an Enterprise Value (EV) of 71.43M.
| EV / Sales | 394.64 |
| EV / EBITDA | -7.45 |
| EV / EBIT | -10.48 |
| EV / FCF | -10.47 |
Financial Position
The company has a current ratio of 7.63, with a Debt / Equity ratio of 0.03.
| Current Ratio | 7.63 |
| Quick Ratio | 7.63 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | -0.03 |
| Debt / FCF | -0.04 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is 117.74% and Return on Invested Capital is -114.16%.
| Return on Equity | 117.74% |
| Return on Assets | 101.31% |
| Return on Invested Capital | -114.16% |
| Revenue Per Employee | $10.06K |
| Profits Per Employee | $528.5K |
| Employee Count | 18 |
| Asset Turnover | 0.02 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 14K |
| Effective Tax Rate | 0.15% |
Stock Price Statistics
The stock price has increased by -10.22% in the last 52 weeks. The beta is 1.63, so Entera Bio Ltd.'s price volatility has been higher than the market average.
| Beta | 1.63 |
| 52-Week Price Change | -10.22% |
| 50-Day Moving Average | 2.11 |
| 200-Day Moving Average | 1.94 |
| Relative Strength Index (RSI) | 30.76 |
| Average Volume (20 Days) | 118.67K |
Income Statement
In the last 12 months, Entera Bio Ltd. had revenue of 181K and earned 9.51M in profits. Earnings per share was 0.25.
| Revenue | 181K |
| Gross Profit | 9K |
| Operating Income | -9.59M |
| Net Income | 9.51M |
| EBITDA | -9.59M |
| EBIT | n/a |
| Earnings Per Share (EPS) | 0.25 |
Balance Sheet
The company has 8.66M in cash and 272K in debt, giving a net cash position of 8.39M.
| Cash & Cash Equivalents | 8.66M |
| Total Debt | 272K |
| Net Cash | 8.39M |
| Retained Earnings | -113.93M |
| Total Assets | 7.74M |
| Working Capital | 6.23M |
Cash Flow
In the last 12 months, operating cash flow was -6.82M and capital expenditures -3K, giving a free cash flow of -6.82M.
| Operating Cash Flow | -6.82M |
| Capital Expenditures | -3K |
| Free Cash Flow | -6.82M |
| FCF Per Share | -0.18 |
Margins
Gross margin is 4.97%, with operating and profit margins of -5295.58% and 5255.8%.
| Gross Margin | 4.97% |
| Operating Margin | -5295.58% |
| Pretax Margin | 5263.54% |
| Profit Margin | 5255.8% |
| EBITDA Margin | -5295.58% |
| EBIT Margin | -5295.58% |
| FCF Margin | -3768.51% |
Dividends & Yields
ENTX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | 11.92% |
| FCF Yield | -8.55% |
Analyst Forecast
The average price target for ENTX is $10, which is 498.8% higher than the current price. The consensus rating is "Buy".
| Price Target | $10 |
| Price Target Difference | 498.8% |
| Analyst Consensus | Buy |
| Analyst Count | 1 |
Scores
| Altman Z-Score | 9.12 |
| Piotroski F-Score | 3 |